[Paris, France – September 2021]
We’re excited to announce that Plantibodies has officially been awarded the Deeptech Label by Bpifrance, France’s public investment bank, along with a €90,000 grant through the BFTE (Bourse French Tech Emergence) program.
This label recognizes early-stage startups developing breakthrough innovations with strong scientific and technological foundations — a powerful endorsement of our plant-based biologics platform.
“This grant is a game-changer,” says Pierre Bauër, CEO and co-founder. “It validates the deeptech nature of our approach and gives us the resources to build the next layer of our platform, from gene to function.”
The BFTE grant will be used to expand early R&D efforts and generate key proof-of-concept data, laying the groundwork for future development and collaborations. The funds will directly support experiments in molecular biology, protein expression, and early formulation work, reinforcing our commitment to build a new standard for biologics using plants.
This milestone also solidifies our place in France’s deeptech ecosystem.We’re grateful for Bpifrance’s trust and thrilled to continue building the future of biotech from the ground up.